Methicillin-resistant staphylococcus aureus (MRSA) infections are caused due to
Staphylococcus aureus bacterium which infects different parts of the body.
These infections are difficult to treat due to high degree of resistance of
these pathogens to the most commonly used antibiotics such as methicillin,
amoxicillin, penicillin and oxacillin. The bacterium infects different parts of
the body namely, skin, surgical wounds, blood streams, lungs, IV or other sites
where the tubes such as catheters enter the body or the urinary tract and cause
infection which can be life threatening.
To Read The Complete Report with TOC :-
MRSA infection is known to spread by casual contact or through
contaminated objects called community associated MRSA (CA MRSA). It may also be
acquired in hospitals or health care settings - healthcare associated MRSA (HA
MRSA) which is the most common form of MRSA infection. Community associated
methicillin resistant S. aureus (CA-MRSA) infections are different from
healthcare associated methicillin resistant S. aureus (HA-MRSA) considering
their epidemiology and the characteristics of the strains which causes the
infection. Overuse of antibiotics and use of potent drugs for less serious
infections may also cause development of MRSA. The symptoms of infection depend
on the site of infection and it can be diagnosed by laboratory testing.
One of the major drivers contributing to the market growth for
MRSA drugs is increase in the prevalence of MRSA infections. In addition,
growth in the government and non-government awareness programs has also become
a key factor in improving the market growth. However, overcoming the tendency
of pathogen for developing resistance to multi-drugs and increase in
competition between the generic market players could impose a challenge to the
market growth.
MRSA can be usually treated by antibiotics such as bactrim and
vancomycin though the pathogen has started developing resistance for these
drugs too owing to its constant adapting power to newly developed antibiotics.
Other options for the treatment of MRSA infection are generics such as
clindamycin and minocycline, and prime brand-names such as Tygacil, Cubicin,
Zyvox, and Synercid. Some of these antibiotics are only available
intravenously. The most effective way of controlling the spread of MRSA is
practicing basic hygiene such as use of disposable gloves, washing hands before
making direct contact with patients as well as proper wound care.
Geographically, North America leads this market and is followed
by Europe. However, increase in the development of healthcare infrastructure in
emerging economies forecasts growth in demand for MRSA drugs in Asia-Pacific
and other parts of the world. Some of the major players in this market include
Takeda Pharmaceutical Company Limited, Merck & Co., Inc, AstraZeneca PLC,
GlaxoSmithKline PLC, Pfizer, Inc., Cubist Pharmaceuticals, Inc., ViroPharma,
Inc., Forest Laboratories, Inc., and Theravance, Inc.
This research report analyzes this market depending on its
market segments, major geographies, and current market trends. Geographies
analyzed under this research report include
·
North
America
·
Asia
Pacific
·
Europe
·
Rest
of the World
This report provides comprehensive analysis of
·
Market
growth drivers
·
Factors
limiting market growth
·
Current
market trends
·
Market
structure
·
Market
projections for upcoming years
This report is a complete study of current trends in the market,
industry growth drivers, and restraints. It provides market projections for the
coming years. It includes analysis of recent developments in technology,
Porter’s five force model analysis and detailed profiles of top industry
players. The report also includes a review of micro and macro factors essential
for the existing market players and new entrants along with detailed value
chain analysis.
To Buy a Copy Of This Report:-
Reasons for Buying this Report
·
This
report provides pin-point analysis for changing competitive dynamics
·
It
provides a forward looking perspective on different factors driving or
restraining market growth
·
It
provides a technological growth map over time to understand the industry growth
rate
·
It
provides a seven-year forecast assessed on the basis of how the market is
predicted to grow
·
It
helps in understanding the key product segments and their future
·
It
provides pin point analysis of changing competition dynamics and keeps you
ahead of competitors
·
It
helps in making informed business decisions by having complete insights of
market and by making in-depth analysis of market segments
·
It
provides distinctive graphics and exemplified SWOT analysis of major market
segments
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment